Pharmacotherapy of circulatory shock.
The rubric "shock" encompasses a wide spectrum of critical events, which if untreated, result in morbidity and mortality. Understanding of the various forms of shock has evolved rapidly in the past 20 years as new laboratory and clinical observations have been published. In this article, the authors discuss the physiology of the shock state, review the circumstances in which shock becomes likely, and review the etiologies and diagnostic characteristics of distributive (septic, spinal, anaphylactoid/anaphylactic), cardiogenic, hypovolemic, and obstructive shock. The rationale and applications of conventional and controversial therapies are discussed. The therapeutic potentials of current lines of shock research are also discussed.
Higgins
T L
TL
Chernow
B
B
D002316:Cardiotonic Agents / Q000627:therapeutic use; D002395:Catecholamines / Q000502:physiology; D005934:Glucagon / Q000627:therapeutic use; D006728:Hormones / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D011941:Receptors, Adrenergic / Q000502:physiology; D012769:Shock / Q000188:drug therapy* / Q000503:physiopathology; D013566:Sympathomimetics / Q000627:therapeutic use; D014882:Water-Electrolyte Balance
D002316:Cardiotonic Agents; D002395:Catecholamines; D006728:Hormones; D011941:Receptors, Adrenergic; D013566:Sympathomimetics; D005934:Glucagon